infectious diseases manifesting in the gastrointestinal tract Flashcards


Set Details Share
created 4 weeks ago by lucy_vrazel
show moreless
Page to share:
Embed this setcancel
COPY
code changes based on your size selection
Size:
X
Show:

1

dental caries disease table

card image

2

dental caries causative agent

a polymicrobial mixture of acid-producing bacteria

3

dental caries mode of transmission

direct contact

4

dental caries virulence factors

adhesion, acid production

5

dental caries culture/diagnosis

N/A

6

dental caries prevention

oral hygiene, fluoride supplementation

7

dental caries treatment

removal of diseased tooth material

8

dental caries epidemiological features

globally, 60% to 90% prevalence in school-age children

9

periodontitis disease table

card image

10

necrotizing ulcerative gingivitis and periodontitis disease table

card image

11

periodontitis causative agents

polymicrobial community including some or all of Tannerella forsythia, Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, and others

12

periodontitis virulence factors

induction of inflammation, enzymatic destruction of tissues

13

periodontitis prevention

oral hygiene

14

periodontitis treatment

removal of plaque and calculus, gum reconstruction, and possibly anti-inflammatory treatments

15

periodontitis epidemiological features

US: smokers = 11%, nonsmokers = 2%, and internationally: 10% to 15% of adults

16

NUG or NUP causative agents

polymicrobial community (treponema vincentii, prevotella intermedia, and fuso bacterium species)

17

NUG or NUP virulence factors

inflammation, invasiveness

18

NUG or NUP prevention

oral hygiene

19

NUG or NUP treatment

debridement of damaged tissue, possibly antibiotics

20

NUG or NUP epidemiological features

N/A

21

mumps disease table

card image

22

mumps causative agent

mumps virus (genus paramyxovirus)

23

mumps mode of transmission

droplet contact

24

mumps virulence factors

spike-induced syncytium formation

25

mumps culture/diagnosis

ELISA for Ab; PCR

26

mumps prevention

MMR live attenuated vaccine

27

mumps treatment

supportive

28

mumps epidemiological features

US: fluctuates between a few hundred cases a year and a few thousand; internationally; epidemic peaks every 2 to 5 years

29

gastritis and gastric ulcers disease table

card image

30

gastritis causative agents

helicobacter pylori

31

gastritis mode of transmission

oral-oral or oral-fecal route likely

32

gastritis virulence factors

adhesins, urease

33

gastritis culture/diagnosis

direct antigen test on stool, urea breath test

34

gastritis prevention

none

35

gastritis treatment

clarithromycin + acid suppression

36

gastritis epidemiological features

US: infection (not disease) rates at 35% of adults; internationally: infection rates at 50%

37

acute diarrhea causative agents

salmonella, shigella, shiga toxin-producing E. coli, other E. colie, campylobacter, clostridioides difficile, vibrio cholerae, and non-cholera vibrio species

38

salmonella disease table

card image

39

shigella disease table

card image

40

shiga toxin-producing E. coli disease table

card image

41

other E. coli disease table

card image

42

campylobacter disease table

card image

43

clostridioides difficile disease table

card image

44

vibrio cholerae disease table

card image

45

non-cholera vibrio species

card image

46

salmonella mode of transmission

vehicle (food, beverage), fecal-oral

47

salmonella virulence factors

adhesions, endotoxin

48

salmonella culture/diagnosis

stool culture, not usually necessary

49

salmonella prevention

food hygiene and personal hygiene

50

salmonella treatment

rehydration; no antibiotic for uncomplicated disease; in complicated disease ciprofloxacin; resistant salmonella is considered a serious threat by the CDC

51

is fever present with salmonella?

usually

52

is blood present in the stool with salmonella?

sometimes

53

salmonella distinctive features

often associated with chickens, reptiles

54

salmonella epidemiological features

US: +/- 1.2 million cases per year; 20% of all cases require hospitalization; death rate of 0.6%; category b bioterrorism agent

55

shigella mode of transmission

fecal-oral, direct contact

56

shigella virulence factors

endotoxin, enterotoxinm and shiga toxins in some strains

57

shigella culture/diagnosis

stool culture; antigen testing for shiga toxin

58

shigella prevention

food hygiene and personal hygiene

59

shigella treatment

azitromycin or ciprofloxacin; drug-resistant shigella is in the CDC's serious threat category

60

is fever present with shigella?

often

61

is blood in the stool with shigella?

often

62

shigella distinctive features

very low in ID50

63

shigella epidemiological features

US: estimated 450,000 cases per year; internationally: 165 million cases per year; category b bioterrorism agent

64

shiga toxin-producing E. coli mode of transmission

vehicle (food, beverage), fecal-oral

65

shiga toxin-producing E.coli virulence factors

shiga toxins; proteins for attachment, secretion, and effacement

66

shiga toxin-producing culture/diagnosis

stool culture, antigen testing for shiga toxin

67

shiga-toxin producing E.coli prevention

avoid live E. coli (cook meat and clean vegetables); stay aware of food recalls

68

shiga-toxin producing E.coli treatment

antibiotics contraindicated, supportive measures

69

is fever present when shiga-toxin producing E.coli?

often

70

is blood in the stool with shiga-toxin producing E.coli?

usually

71

shiga toxin-producing distinctive features

hemolytic uremic syndrome

72

shiga toxin-producing epidemiological features

internationally: causes HUS in 10% of patients; 25% of HUS patients suffer neurological complications, 50% have chronic renal sequelae; category b bioterrorism agent

73

other E.coli mode of transmission

vehicle, fecal-oral

74

other E.coli virulence factors

various: proteins for attachment, secretion, effacement; heat-liable, and/or heat-stable exotoxins; invasiveness

75

other E.coli culture/diagnosis

stool culture not usually necessary in absence of blood, fever

76

other E.coli prevention

food and personal hygiene

77

other E.coli treatment

rehydration, anti-motility agent

78

other E.coli fever present

sometimes

79

other E.coli blood in stool

sometimes

80

other E.coli distinctive features

ETEC, EIEC, EPEC, DAEC, EAEC

81

campylobacter mode of transmission

vehicle (food, water), fecal-oral

82

campylobacter virulence factors

adhesins, exotoxin, and induction of autoimmunity

83

campylobacter culture/diagnosis

stool culture not usually necessary; dark-field microscopy

84

campylobacter prevention

food and personal hygiene

85

campylobacter treatment

rehydration; azithromycin in severe cases

86

campylobacter fever present

usually

87

campylobacter blood in stool

no

88

campylobacter distinctive features

guillain-barre syndrome

89

campylobacter epidemiolgica features

US: 1.3 million cases per year; internationally: 400 million cases per year

90

clostridioides difficle mode of transmission

endogenous (normal biota)

91

clostridioides difficle virulence factors

enterotoxins A and B

92

clostridioides difficle culture/diagnosis

stool culture, PCR, ELISA demonstration of toxins in stool

93

clostridioides difficle prevention

N/A

94

clostridioides difficle treatment

metronidazole in mild cases, vancomycin for severe, fecal transplants, resistant strains are in the CDC's urgent threat category

95

clostridioides difficle fever present

sometimes

96

clostridioides difficle blood in stool

not usually; mucus prominent

97

clostridioides difficle distinctive features

associated with disruption of normal biota

98

clostridioides difficle epidemiologic features

US: 500,000 cases per year

99

vibrio cholerae mode of transmission

vehicle (water and some foods), fecal-oral

100

vibrio cholerae virulence factors

cholera toxin

101

vibrio cholerae culture/diagnosis

clinical diagnosis, microscopic techniques, serological detection of antitoxin

102

vibrio cholerae prevention

water and food hygiene

103

vibrio cholerae treatment

rehydration and possibly doxycycline

104

vibrio cholerae fever present

no

105

vibrio cholerae blood in stool

no

106

vibrio cholerae distinctive features

rice-water stools

107

vibrio cholerae epidemiological features

global estimate: 21,000-143,000 deaths annually; category b bioterrorism agent

108

non-cholera vibrio species mode of transmission

vehicle (food or natural bodies of water)

109

non-cholera vibrio species virulence factors

N/A

110

non-cholera vibrio species culture diagnosis

culture of stool or blood

111

non-cholera vibrio species prevention

avoiding raw shellfish

112

non-cholera vibrio species treatment

doxycycline

113

non-cholera vibrio species fever present

yes

114

non-cholera vibrio species blood in stoool

no

115

non-cholera vibrio species distinctive features

sepsis can follow

116

non-cholera vibrio species epidemiological features

cause: 90% of seafood-related deaths in the US

117

nonbacterial causes of acute diarrhea

cryptosporidium, rotavirus, norovirus

118

cryptosporidium mode of transmission

vehicle (water, food), fecal-oral

119

cryptosporidium virulence factors

intracellular growth

120

cryptosporidium culture/diagnosis

acid-fast staining, ruling out bacteria

121

cryptosporidium prevention

water treatment, proper food handling

122

cryptosporidium treatment

none of nitazoxanide

123

cryptosporidium fever present

often

124

cryptosporidium blood in stool

not usually

125

cryptosporidium distinctive features

resistant to chlorine disinfection

126

cryptosporidium epidemiological features

US: estimated 748,000 cases per year; 30% seropositive; category b bioterrorism agent

127

rotavirus mode of transmission

fecal-oral, vehicle, formite

128

rotavirus virulence factors

N/A

129

rotavirus culture/diagnosis

rapid antigen test

130

rotavirus prevention

oral live-virus vaccine

131

rotavirus treatment

rehydration

132

rotavirus fever present

often

133

rotavirus blood in stool

no

134

rotavirus distinctive features

severe in infants

135

rotavirus epidemiological features

US: 2-3 million cases per year internationally; 125 million cases of infantile diarrhea annually

136

norovirus mode of transmission

indirect, vehicle (food), direct contact

137

norovirus virulence factors

limited immunity to reinfection

138

norovirus culture/diagnosis

rapid antigen test

139

norovirus prevention

hygiene

140

norovirus treatment

rehydration

141

norovirus fever present

sometimes

142

norovirus blood in stool

no

143

norovirus distinctive features

resistant to disinfection

144

norovirus epidemiological features

US: second most common cause of foodborne illness hospitalizations

145

are fevers present in acute diarrhea with vomitting?

not usually

146

is blood in stool present in acute diarrhea with vomitting?

no

147

acute diarrhea with vomiting causative agents

staphylococcus aureus exotoxin, bacillus cereus exotoxin, clostridium perfringens exotoxin

148

staphylococcus aureus exotoxin mode of transmission

vehicle (food)

149

staphylococcus aureus exotoxin virulence factors

heat-stable exotoxin

150

staphylococcus aureus exotoxin culture/diagnosis

usually based on epidemiological evidence

151

staphylococcus aureus exotoxin prevention

proper food handling

152

staphylococcus aureus exotoxin treatment

supportive

153

staphylococcus aureus exotoxin distinctive features

suspect in foods with high salt or sugar content

154

staphylococcus aureus exotoxin epidemiological features

US: estimated 240,000 cases per year; category b bioterrorism agent

155

bacillus cereus exotoxin mode of transmission

vehicle (food)

156

bacillus cereus exotoxin virulence factors

heat-stable toxin, heat-liable toxin

157

bacillus cereus exotoxin culture/diagnosis

microscopic analysis of food or stool

158

bacillus cereus exotoxin prevention

proper food handling

159

bacillus cereus exotoxin treatment

supportive

160

bacillus cereus exotoxin distinctive features

two forms: emetic and diarrheal

161

bacillus cereus exotoxin epidemiological features

US: estimated 63,000 cases per year

162

clostridium perfringens exotoxin mode of transmission

vehicle (food)

163

clostridium perfringens exotoxin virulence factors

heat-liable toxin

164

clostridium perfringens exotoxin culture/diagnosis

detection of toxin in stool

165

clostridium perfringens exotoxin prevention

proper food handling

166

clostridium perfringens exotoxin treatment

supportive

167

clostridium perfringens exotoxin distinctive features

acute abdominal pain

168

clostridium perfringens exotoxin epidemiological features

US: estimated 966,000 cases per year, category b bioterrorism agent

169

clostridium perfringens exotoxin disease table

card image

170

bacillus cereus exotoxin disease table

card image

171

staphylococcus aureus exotoxin disease table

card image

172

chronic disease causative agents

enteroaggregative E.coli (EAEC), cyclospora cayetanensis, giardia lamblia, entamoeba histolytica

173

enteroaggregative E.coli (EAEC) mode of transmission

vehicle (food, water), fecal-oral

174

enteroaggregative E.coli (EAEC) virulence factors

?

175

enteroaggregative E.coli (EAEC)

difficult to distinguish from other E. coli

176

enteroaggregative E.coli (EAEC) treatment

rehydration of ciprofioxacin

177

enteroaggregative E.coli (EAEC) blood in stool

sometimes, mucus also

178

enteroaggregative E.coli (EAEC) fever present

no

179

enteroaggregative E.coli (EAEC) distinctive features

chronic in the malnourished

180

enteroaggregative E.coli (EAEC) epidemiological features

developing countries: 87% of chronic diarrhea in children >2 years old

181

cyclospora cayetanensis mode of transmission

fecal-oral, vehicle

182

cyclospora cayetanensis virulence factors

invasiveness

183

cyclospora cayetanensis culture/diagnosis

stool examination, PCR

184

cyclospora cayetanensis prevention

washing, cooking food, and personal hygiene

185

cyclospora cayetanensis treatment

TMP-SMZ

186

cyclospora cayetanensis fever present

usually

187

cyclospora cayetanensis blood in stool

no

188

cyclospora cayetanensis distinctive features

N/A

189

cyclospora cayetanensis epidemiological features

US: estimated 16,000 cases per year; internationally: endemic 27 countries, mostly tropical

190

giardia lamblia mode of transmission

vehicle, fecal-oral, direct and indirect contact

191

giardia lamblia virulence factors

attachment to intestines alters mucosa

192

giardia lamblia culture/diagnosis

stool examination, ELISA

193

giardia lamblia prevention

water hygiene, personal hygiene

194

giardia lamblia treatment

tinidazole, nitazoxanide

195

giardia lamblia fever present

not usually

196

giardia lamblia blood in stool

no, mucus present (greasy and foul smelling)

197

giardia lamblia distinctive features

frequently occurs in backpackers, campers

198

giardia lamblia epidemiological features

US: estimated 1.2 million cases per year; internationally: prevalence rates from 2% to 5% in industrialized world

199

entamoeba histolytica mode of transmission

vehicle, fecal-oral

200

entamoeba histolytica virulence factors

lytic enzymes, induction of apoptosis, invasiveness

201

entamoeba histolytica culture/diagnosis

PCR, stool examination, ELISA, serology

202

entamoeba histolytica prevention

water hygiene, personal hygiene

203

entamoeba histolytica treatment

metronidazole or paromomycin

204

entamoeba histolytica fever present

yes

205

entamoeba histolytica blood in stool

yes

206

entamoeba histolytica distinctive features

N/A

207

entamoeba histolytica epidemiological features

internationally: 40,000-100,000 deaths annually

208

hepatitis A or E virus mode of transmission

fecal-oral, vehicle

209

hepatitis A or E virus culture/diagnosis

IgM serology

210

hepatitis A or E virus prevention

hepatitis a vaccine or combined; HAV/HBV vaccine

211

hepatitis A or E virus treatment

HAV: hepatitis A vaccine or immune globulin; HEV: immune globulin

212

hepatitis A or E virus incubation period

2-4 weeks

213

hepatitis A or E virus epidemiological features

hepatitis A, US: 20,000 cases annually and 40% of adults show evidence of prior infection; internationally: 1.4 million cases per year; hepatitis E, internationally: 20 million infections per year; 60% in east and southeast asia

214

hepatitis B virus mode of transmission

parenteral (blood contact), direct contact (especially sexual), vertical

215

hepatitis B virus virulence factors

latency

216

hepatitis B virus prevention

HMV recombinant vaccine

217

hepatitis B virus culture/diagnosis

ELISA

218

hepatitis B virus treatment

interferon, tenofovir, or entecavir

219

hepatitis B virus incubation period

1-6 months

220

hepatitis B virus epidemiological features

US: 19,000 new cases per year; 800,000 to 2.2 million have chronic infection internationally: 240 million

221

hepatitis C virus mode of transmission

parenteral (blood contact), vertical

222

hepatitis C virus virulence factors

core protein suppresses immune function

223

hepatitis C virus culture/diagnosis

serology, also PCR

224

hepatitis C virus prevention

N/A

225

hepatitis C virus treatment

sofosbuvir + simeprevir

226

hepatitis C virus incubation period

2-8 weeks

227

hepatitis C virus epidemiological features

US: estimated 30,000 new diagnoses per year; internationally: 150 million chronically infected

228

intestinal distress causative agents

enterobius vermicularis (pinworm), trichuris trichiura (whipworm), diphyllobothrium latum (fish tapeworm), hymenolepis nana and H. diminuta

229

enterobius vermicularis (pinworm) disease table

card image

230

enterobius vermicularis (pinworm) modes of transmission

cycle A: vehicle (food, water), formites, self-inoculation

231

enterobius vermicularis (pinworm) culture/diagnosis

adhesive tape + microscopy

232

enterobius vermicularis (pinworm) prevention

hygiene

233

enterobius vermicularis (pinworm) treatment

mebendazole, piperazine

234

enterobius vermicularis (pinworm) distinctive features

common in the US

235

enterobius vermicularis (pinworm) epidemiological features

US: up to 40 million cases per year

236

trichuris trichiura (whipworm) disease table

card image

237

trichuris trichiura (whipworm) mode of transmission

cycle A: vehicle (soil), fecal-oral

238

trichuris trichiura (whipworm) virulence factors

burrowing and invasiveness

239

trichuris trichiura (whipworm) culture/diagnosis

blood count, serology, egg or worm detection

240

trichuris trichiura (whipworm) prevention

hygiene, sanitation

241

trichuris trichiura (whipworm) treatment

mebendazole

242

trichuris trichiura (whipworm) distinctive features

humans sole host

243

trichuris trichiura (whipworm) epidemiological features

US: prevalence approx 0.1% internationally: prevalence as high as 80% in southeast asia, africa, the caribbeam, and central and south america

244

diphyllobothrium latum (fish tapeworm) disease table

card image

245

diphyllobothrium latum (fish tapeworm) mode of transmission

cycle C; vehicle (seafood)

246

diphyllobothrium latum (fish tapeworm) virulence factors

vitamin B12 usage

247

diphyllobothrium latum (fish tapeworm) culture/diagnosis

blood count, serology, egg or worm detection

248

diphyllobothrium latum (fish tapeworm) prevention

cook meat

249

diphyllobothrium latum (fish tapeworm) treatment

praziquantel

250

diphyllobothrium latum (fish tapeworm) distinctive features

largest human tapeworm (up to 30ft long); anemia

251

diphyllobothrium latum (fish tapeworm) epidemiological features

estimated 20 million infections worldwide

252

hymenolepis nana and H. diminuta disease table

card image

253

hymenolepis nana and H. diminuta mode of transmission

cycle C; vehicle (ingesting insects), fecal-oral

254

hymenolepis nana and H. diminuta virulence factors

N/A

255

hymenolepis nana and H. diminuta culture/diagnosis

blood count, serology, egg or worm detection

256

hymenolepis nana and H. diminuta prevention

hygienic environment

257

hymenolepis nana and H. diminuta treatment

praziquantel

258

hymenolepis nana and H. diminuta distinctive features

most common tapeworm infection

259

hymenolepis nana and H. diminuta epidemiological features

US: prevalence approximately 0.4%; internationally: the single most prevalent tapeworm infection

260

intestinal distress plus migratory symptoms causative agents

toxocara species, ascaris lumbricoides (intestinal roundworm), necator americanus and ancylostoma duodenale (hookworms)

261

toxocara species disease table

cycle A; dog or cat feces

262

toxocara species culture/diagnosis

blood count, serology, egg or worm detection

263

toxocara species prevention

hygiene

264

toxocara species treatment

albendazole

265

toxocara species distinctive features

can cause migration symptoms or blindness

266

toxocara species epidemiological features

nearly 100% of newborn puppies in the US are infected; 14% of people in the US have been infected; considered a neglected parasitic infection

267

ascaris lumbricoides (intestinal roundworm)

card image

268

ascaris lumbricoides (intestinal roundworm) mode of transmission

cycle A: vehicle (soil/fecal-oral), formites, self-inoculation

269

ascaris lumbricoides (intestinal roundworm) virulence factors

induction of hypersensitivity, adult worm migration, abdominal obstruction

270

ascaris lumbricoides (intestinal roundworm) culture/diagnosis

blood count, serology, egg or worm detection

271

ascaris lumbricoides (intestinal roundworm) prevention

hygiene

272

ascaris lumbricoides (intestinal roundworm) treatment

albendazole

273

ascaris lumbricoides (intestinal roundworm) distinctive features

most cases mild, unnoticed

274

ascaris lumbricoides (intestinal roundworm) epidemiological features

internationally: up to 25% prevalence, 80,000-100,000 deaths per year

275

necator americanus and ancylostoma duodenale (hookworms) disease table

card image

276

necator americanus and ancylostoma duodenale (hookworms) mode of transmission

cycle B: vehicle (soil), formite

277

necator americanus and ancylostoma duodenale (hookworms) virulence factors

induction of hypersensitivity, adult worm migration, abdominal obstruction

278

necator americanus and ancylostoma duodenale (hookworms) culture/diagnosis

blood count, serology, egg or worm detection

279

necator americanus and ancylostoma duodenale (hookworms) prevention

sanitation

280

necator americanus and ancylostoma duodenale (hookworms) treatment

albendazole

281

necator americanus and ancylostoma duodenale (hookworms) distinctive features

penetrates skin, serious intestinal symptoms

282

necator americanus and ancylostoma duodenale (hookworms) epidemiological features

US: widespread in southeast until early 1900s; internationally: 800 million infected

283

cysticercosis disease table

card image

284

cysticercosis mode of transmission

cycle C: vehicle (pork), fecal-oral

285

cysticercosis culture/diagnosis

blood count, serology, egg or worm detection

286

cysticercosis prevention

cook meat, avoid pig feces

287

cysticercosis treatment

praziquantel

288

cysticercosis distinctive features

ingesting larvae embedded in pork leads to intestinal tapeworms: ingesting eggs (fecal-oral route) causes cysticercosis, larval cysts embedded in tissue of new host

289

cysticercosis epidemiological features

US: considered a neglected parasitic infection, common cause of seizures; internationally: very common in latin america and asia

290

liver and intestinal disease table

card image

291

liver and intestinal causative agents

opisthorchis sinesis, clonorchis sinesis, and fasciola hepatica

292

opisthorchis sinesis, clonorchis sinesis mode of transmission

cycle D: vehicle (fish or crustaceans)

293

opisthorchis sinesis, clonorchis sinesis culture/diagnosis

blood count, serology, egg or worm detection

294

opisthorchis sinesis, clonorchis sinesis prevention

cook food, sanitation of water

295

opisthorchis sinesis, clonorchis sinesis treatment

praziquantel

296

opisthorchis sinesis, clonorchis sinesis distinctive features

live in liver

297

fasciola hepatica mode of transmission

cycle D: vehicle (water and water plants)

298

fasciola hepatica culture/diagnosis

blood count, serology, egg or worm detection

299

fasciola hepatica prevention

sanitation of water

300

fasciola hepatica treatment

triclabendcazole

301

fasciola hepatica distinctive features

live in liver and gallbladder

302

muscle and neurological symptoms disease table

card image

303

muscle and neurological symptoms causative agents

trichinella species

304

muscle and neurological symptoms culture/diagnosis

serology combined with clinical picture; muscle biopsy

305

muscle and neurological symptoms prevention

cook meat

306

muscle and neurological symptoms treatment

mebendazole, steroids

307

muscle and neurological symptoms distinctive features

brain and heart involvement can be fatal

308

muscle and neurological symptoms epidemiological features

US: 20 cases per year; internationally: 10,000 cases per year

309

schistosomiasis liver disease table

card image

310

schistosomiasis causative agent

schistosoma mansoni, S. japonicum

311

schistosomiasis mode of transmission

cycle D: vehicle (contaminated water)

312

schistosomiasis virulence factors

antigenic "cloaking"

313

schistosomiasis culture/diagnosis

identification of eggs in feces, scarring of intestines detected by endoscopy

314

schistosomiasis prevention

avoiding contaminated vehicles

315

schistosomiasis treatment

praziquantel

316

schistosomiasis distinctive features

penetrates skin, lodges in blood vessels of intestine, damages liver

317

schistosomiasis epidemiological features

internationally: 230 million new infections per year by these and the urinary schistosome

318

gram-positive, endospore-forming bacteria

clostridioides difficile (antibiotic-associated diarrhea), bacillus cereus (food poisoning), clostridium perfringens (food poisoning)

319

gram-positive bacteria

streptococcus mutans (dental caries), streptococcus sobrinus (dental caries), staphylococcus aureus (food poisoning)

320

gram-negative bacteria

periodontal disease, helicobacter pylori, salmonella, shigella, escherichia coli STEC, other E.coli, campylobacter jejuni, vibrio cholera, non-cholera vibrio species

321

DNA viruses

hepatitus B virus

322

RNA viruses

mumps, rotavirus, norovirus, hepatitis A, E, and C

323

protozoa

cryptosporidium, cyclospora cayetanesis, giardia duodenalis, enatmoeba histolytica

324

helminths-nematodes

enterobius vermicularis, trichuris trichiura, toxocara species, ascaris lumbricoides, necator americanus, ancylostoma duodenale, trichinella species

325

helminths-cestodes

diphyllobothrium latum, hymenolepis nana, H. diminuta, taenia solium, opisthorchis sinensis, clonorchis sinensis

326

helminths-trematodes

fasciola hepatica, schistosoma mansoni, S. japonicum